Literature DB >> 21769584

Regional expression of P2Y(4) receptors in the rat central nervous system.

Xianmin Song1, Wei Guo, Qiang Yu, Xiaofeng Liu, Zhenghua Xiang, Cheng He, Geoffrey Burnstock.   

Abstract

P2Y receptors are G protein-coupled receptors composed of eight known subunits (P2Y(1, 2, 4, 6, 11, 12, 13, 14)), which are involved in different functions in neural tissue. The present study investigates the expression pattern of P2Y(4) receptors in the rat central nervous system (CNS) using immunohistochemistry and in situ hybridization. The specificity of the immunostaining has been verified by preabsorption, Western blot, and combined use of immunohistochemistry and in situ hybridization. Neurons expressing P2Y(4) receptors were distributed widely in the rat CNS. Heavy P2Y(4) receptor immunostaining was observed in the magnocellular neuroendocrine neurons of the hypothalamus, red nucleus, pontine nuclei, mesencephalic trigeminal nucleus, motor trigeminal nucleus, ambiguous nucleus, inferior olive, hypoglossal nucleus, and dorsal motor vagus nucleus. Both neurons and astrocytes express P2Y(4) receptors. P2Y(4) receptor immunostaining signals were mainly confined to cell bodies and dendrites of neurons, suggesting that P2Y(4) receptors are mainly involved in regulating postsynaptic events. In the hypothalamus, all the vasopressin (VP) and oxytocin (OT) neurons and all the orexin A neurons were immunoreactive for P2Y(4) receptors. All the neurons expressing P2Y(4) receptors were found to express N-methyl-D: -aspartate receptor 1 (NR1). These data suggest that purines and pyrimidines might be involved in regulation of the release of the neuropeptides VP, OT, and orexin in the rat hypothalamus via P2Y(4) receptors. Further, the physiological and pathophysiological functions of the neurons may operate through coupling between P2Y(4) receptors and NR1.

Entities:  

Year:  2011        PMID: 21769584      PMCID: PMC3224639          DOI: 10.1007/s11302-011-9246-7

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  64 in total

1.  Coexpression of functional P2X and P2Y nucleotide receptors in single cerebellar granule cells.

Authors:  Cristina Hervás; Raquel Pérez-Sen; Ma Teresa Miras-Portugal
Journal:  J Neurosci Res       Date:  2003-08-01       Impact factor: 4.164

Review 2.  Restoration of brain energy metabolism as the function of sleep.

Authors:  J H Benington; H C Heller
Journal:  Prog Neurobiol       Date:  1995-03       Impact factor: 11.685

3.  Localization of P2X purinoceptor transcripts in the rat nervous system.

Authors:  E J Kidd; C B Grahames; J Simon; A D Michel; E A Barnard; P P Humphrey
Journal:  Mol Pharmacol       Date:  1995-10       Impact factor: 4.436

Review 4.  Narcolepsy: a neurodegenerative disease of the hypocretin system?

Authors:  A N van den Pol
Journal:  Neuron       Date:  2000-09       Impact factor: 17.173

5.  Genetic ablation of orexin neurons in mice results in narcolepsy, hypophagia, and obesity.

Authors:  J Hara; C T Beuckmann; T Nambu; J T Willie; R M Chemelli; C M Sinton; F Sugiyama; K Yagami; K Goto; M Yanagisawa; T Sakurai
Journal:  Neuron       Date:  2001-05       Impact factor: 17.173

6.  P2X5 receptors are expressed on neurons containing arginine vasopressin and nitric oxide synthase in the rat hypothalamus.

Authors:  Zhenghua Xiang; Cheng He; Geoffrey Burnstock
Journal:  Brain Res       Date:  2006-06-12       Impact factor: 3.252

7.  Interaction between P2Y and NMDA receptors in layer V pyramidal neurons of the rat prefrontal cortex.

Authors:  Kerstin Wirkner; Laszlo Köles; Susanne Thümmler; Julia Luthardt; Wolfgang Poelchen; Heike Franke; Susanna Fürst; Peter Illes
Journal:  Neuropharmacology       Date:  2002-03       Impact factor: 5.250

8.  P2Y receptors modulate ion channel function through interactions involving the C-terminal domain.

Authors:  So Yeong Lee; Samuel C Wolff; Robert A Nicholas; Scott M O'Grady
Journal:  Mol Pharmacol       Date:  2003-04       Impact factor: 4.436

9.  Role of the metabotropic P2Y(4) receptor during hypoglycemia: cross talk with the ionotropic NMDAR1 receptor.

Authors:  Fabio Cavaliere; Susanna Amadio; Daniela F Angelini; Giuseppe Sancesario; Giorgio Bernardi; Cinzia Volonté
Journal:  Exp Cell Res       Date:  2004-10-15       Impact factor: 3.905

10.  Selected P2 purinoceptor modulators prevent glutamate-evoked cytotoxicity in cultured cerebellar granule neurons.

Authors:  C Volonté; D Merlo
Journal:  J Neurosci Res       Date:  1996-07-15       Impact factor: 4.164

View more
  5 in total

1.  P2Y4 receptor-mediated pinocytosis contributes to amyloid beta-induced self-uptake by microglia.

Authors:  Hui-quan Li; Cong Chen; Ying Dou; Hang-jun Wu; Yi-jun Liu; Hui-Fang Lou; Jian-min Zhang; Xiao-ming Li; Hao Wang; Shumin Duan
Journal:  Mol Cell Biol       Date:  2013-09-03       Impact factor: 4.272

2.  ATP stimulates rat hypothalamic sympathetic neurons by enhancing AMPA receptor-mediated currents.

Authors:  Hildebrando Candido Ferreira-Neto; Vagner R Antunes; Javier E Stern
Journal:  J Neurophysiol       Date:  2015-04-22       Impact factor: 2.714

3.  Reactive oxygen species play a role in P2X7 receptor-mediated IL-6 production in spinal astrocytes.

Authors:  Frances M Munoz; Priya A Patel; Xinghua Gao; Yixiao Mei; Jingsheng Xia; Sofia Gilels; Huijuan Hu
Journal:  Purinergic Signal       Date:  2020-03-07       Impact factor: 3.765

4.  4-Alkyloxyimino derivatives of uridine-5'-triphosphate: distal modification of potent agonists as a strategy for molecular probes of P2Y2, P2Y4, and P2Y6 receptors.

Authors:  P Suresh Jayasekara; Matthew O Barrett; Christopher B Ball; Kyle A Brown; Eva Hammes; Ramachandran Balasubramanian; T Kendall Harden; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2014-04-18       Impact factor: 7.446

Review 5.  Purinergic Receptors of the Central Nervous System: Biology, PET Ligands, and Their Applications.

Authors:  Hamideh Zarrinmayeh; Paul R Territo
Journal:  Mol Imaging       Date:  2020 Jan-Dec       Impact factor: 4.488

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.